Evaluation of Topical ATR12-351 in Adults With Netherton Syndrome
NCT06137157
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Netherton Syndrome
Interventions
DRUG:
ATR12-351
Sponsor
Azitra Inc.